|
2026-09-08 20:02 |
2026-09-04 |
SRPT |
Sarepta Therapeutics, Inc. |
Rothfuss Cristin |
EVP, GC |
F - Tax |
$22.22 |
-22.0K |
115.5K |
-16% |
-$489.4K |
|
2026-03-13 |
2026-03-11 |
SRPT |
Sarepta Therapeutics, Inc. |
Rothfuss Cristin |
EVP, GC |
F - Tax |
$17.03 |
-974 |
137.5K |
-0.7% |
-$16.6K |
| M |
2026-03-11 |
2026-03-09 |
SRPT |
Sarepta Therapeutics, Inc. |
Rothfuss Cristin |
EVP, GC |
F - Tax |
$16.95 |
-830 |
138.9K |
-0.6% |
-$14.1K |
|
2026-03-03 |
2026-03-02 |
SRPT |
Sarepta Therapeutics, Inc. |
Rothfuss Cristin |
EVP, GC |
F - Tax |
$16.20 |
-408 |
139.3K |
-0.3% |
-$6,610 |
|
2025-12-02 |
2025-11-28 |
SRPT |
Sarepta Therapeutics, Inc. |
Rothfuss Cristin |
EVP, GC |
F - Tax |
$21.12 |
-229 |
139.8K |
-0.2% |
-$4,836 |
| M |
2025-09-05 |
2025-09-03 |
SRPT |
Sarepta Therapeutics, Inc. |
Rothfuss Cristin |
EVP, GC |
A - Grant |
$0.00 |
+118.9K |
115.0K |
New |
$0 |
| D |
2025-03-11 |
2025-03-10 |
SRPT |
Sarepta Therapeutics, Inc. |
Rothfuss Cristin |
EVP, GC |
F - Tax |
$100.13 |
-491 |
12.8K |
-4% |
-$49.2K |
| D |
2025-03-11 |
2025-03-10 |
SRPT |
Sarepta Therapeutics, Inc. |
Rothfuss Cristin |
EVP, GC |
A - Grant |
— |
+8,276 |
21.1K |
+64% |
— |
| M |
2025-03-10 |
2025-03-07 |
SRPT |
Sarepta Therapeutics, Inc. |
Rothfuss Cristin |
EVP, GC |
F - Tax |
$103.70 |
-1,478 |
11.8K |
-11% |
-$153.3K |
| M |
2025-03-06 |
2025-03-04 |
SRPT |
Sarepta Therapeutics, Inc. |
Rothfuss Cristin |
EVP, GC |
F - Tax |
$101.34 |
-584 |
13.0K |
-4% |
-$59.2K |
|
2025-03-04 |
2025-03-03 |
SRPT |
Sarepta Therapeutics, Inc. |
Rothfuss Cristin |
EVP, GC |
F - Tax |
$103.77 |
-391 |
13.6K |
-3% |
-$40.6K |
| D |
2024-11-29 |
2024-11-26 |
SRPT |
Sarepta Therapeutics, Inc. |
Rothfuss Cristin |
EVP, GC |
A - Grant |
$0.00 |
+2,000 |
13.8K |
+17% |
$0 |